SEC Form 4 · accession 0001209191-15-025168
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mary Oneil Mundinger
Director
Period of report
Aug 8, 2012
Accepted (ET)
Mar 11, 2015 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 8, 2012 | G | 46,535 | $0.00 | D | 354,644 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction involved a gift of securities by the reporting person to a trust. The reporting person has no beneficial ownership or pecuniary interest in the shares held by such trust.